<DOC>
	<DOCNO>NCT00481117</DOCNO>
	<brief_summary>This study intend evaluate safe well tolerate LY2405319 compound give people 7 day ( Part 1 ) 28 day ( Part 2 ) . This study intend also determine positive effect lower level glucose people type 2 diabetes .</brief_summary>
	<brief_title>Safety , Tolerability , Effect LY2405319 After Multiple Injections Subjects With Type 2 Diabetes</brief_title>
	<detailed_description>Subjects Part 1 randomize receive LY2405319 placebo 7 day one 4 dose level group , ascend order : 1 mg , 3 mg , 10 mg , 20 mg . Subjects Part 2 randomized receive LY2405319 placebo 28 day , receive dose level determine well tolerate Part 1 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Men woman without child bearing capability Ages 35 70 year Type 2 diabetic subject , diagnose least 3 month Average body weight ( relative height ) Willing available duration study Significant medical illness ( except Type 2 diabetes ) Abnormal 12lead electrocardiogram ( ECG ) Current previous use insulin great 7 day control diabetes Regular use drug abuse Excessive alcohol use</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>